Skip to main content
. 2022 Jul 1;13:909526. doi: 10.3389/fphar.2022.909526

TABLE1.

DNA nanoparticles in chemotherapy.

Chemotherapeutic Drugs DNA Nanostructures Modification Effect Ref
Doxorubicin DNA tetrahedron Folate receptor Apoptosis promoting Zhang et al. (2017b)
KLA peptide Drug delivery and apoptosis promoting Yan et al. (2020)
AS1411 + MUC1 aptamer Breast cancer cell imaging and drug delivery Liu et al. (2018a)
Affibody Selectivity and inhibition of breast cancer cells Zhang et al. (2017c)
DNA octahedron Folate Selective targeting Raniolo et al. (2018)
DNA icosahedron MUC1 aptamer Efficient and specific internalization for killing epithelial cancer cells Chang et al. (2011)
DNA NFs Sgc8 Nuclease resistance and binding of different functional moieties Lv et al. (2015)
DNA triangle and tube - Increased doxorubicin cellular internalization and elevated susceptibility to drug-resistant adenocarcinoma cells Bertrand et al. (2014)
RCA-based nanostructures Imotif sequence, Sgc8 pH-Responsive Drug Delivery Zhao et al. (2018)
Daunorubicin DNA nanorod - Circumvent drug-resistance mechanisms in a leukemia model Halley et al. (2016)
Platinum DNA tetrahedron - Targeted platinum drug delivery Wu et al. (2019)
DNA icosahedron Telomerase-Responsive Precise delivery of platinum nanodrugs to cisplatin-resistant cancer Ma et al. (2018)